Literature DB >> 3573681

[Effect of an allopurinol/benzbromaron preparation on the composition of urine in a circadian course].

A Hesse, W Schneeberger, W Vahlensieck.   

Abstract

In 13 patients suffering from recurrent calcium-oxalate urolithiasis the circadian course in the excretion of urinary components was investigated before and during treatment with a combination of allopurinol and benzbromarone. The patients were given a diet standardized in food and liquid intake. Urine was collected for 3 days every 3 h from the 7th day of standard diet. On days 8 and 9 each patient received one tablet of the combination. On all 3 days of urine collection a constant circadian course of urine volume was observed; pH values also showed a nearly identical course on all 3 days with increased daytime and low night values. Maximum excretion of uric acid under dietary conditions was discovered between 11 a.m. and 5 p.m. (day 7). After the first application of the compound (day 8, 8 a.m.) a transient increase in uric acid excretion was observed in the third collection period (2-5 p.m.), followed by a sharp decrease. Following the second application (day 9) the transient increase of the uric acid excretion was clearly diminished. Uric acid excretion in the 24-h urine also decreased steadily from 3.46 mmol/day (control) to 3.25 and 3.06 mmol/day (treatment). Serum uric acid decreased significantly from 324.5 to 275.6 mumol/l. After the first application of the compound (day 8) moderate changes of the urinary components - oxalic acid, Na, K, and chloride - significant changes of Ca were observed, whereas after the second application of the compound (day 9) the values no longer differed from control values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3573681     DOI: 10.1007/bf01715849

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  Turbidimetric analysis of inorganic sulfate in serum, plasma and urine.

Authors:  F BERGLUND; B SORBO
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

2.  Allopurinol treatment of uric-acid disorders in calcium-stone formers.

Authors:  F L Coe; L Raisen
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

3.  Determination of serum creatinine by a direct colorimetric method.

Authors:  D Heinegård; G Tiderström
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

4.  [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].

Authors:  D P Mertz; K Borner
Journal:  Med Welt       Date:  1983-09-09

5.  Circadian rhythm of lithogenic substances in the urine.

Authors:  E W Vahlensieck; D Bach; A Hesse
Journal:  Urol Res       Date:  1982

6.  Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate.

Authors:  C Y Pak; O Waters; L Arnold; K Holt; C Cox; D Barilla
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

Review 7.  Symposium on renal lithiasis. Renal lithiasis in review.

Authors:  B Finlayson
Journal:  Urol Clin North Am       Date:  1974-06       Impact factor: 2.241

8.  Urinary excretion of urate in patients with calcium oxalate stone disease.

Authors:  H G Tiselius; L Larsson
Journal:  Urol Res       Date:  1983

9.  [Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].

Authors:  W Löffler; W Gröbner; N Zöllner
Journal:  Arzneimittelforschung       Date:  1983

10.  [Prevention of urinary calculi by means of a benzbromarone-citrate combination].

Authors:  D Bach; A Hesse; A Strenge; W Vahlensieck
Journal:  Fortschr Med       Date:  1980-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.